Mounjaro Kwikpen 2.5mg Pre-Filled Pen 0.6ml - 4 Doses

• Pre-filled, disposable pen that delivers a single fixed dose of 2.5mg per weekly injection
• Subcutaneously administered
• Active Ingredient: Tirzepatide
• Contains 4 fixed doses
• Safety Information: This drug should not be used in type 1 diabetes, in children, or during pregnancy

Mounjaro (tirzepatide) 2.5mg is the first and lowest dose prescribed for adults with type 2 diabetes to begin their treatment. This once-weekly injectable medicine is a dual GIP and GLP-1 receptor agonist, a unique class of drugs that works by helping your body naturally produce more insulin when blood sugar levels are high. It also reduces the amount of glucose produced by the liver and slows down digestion.

The 2.5mg dose is specifically intended for treatment initiation to help your body gradually adjust to the medication, which can reduce the risk of gastrointestinal side effects. It is not designed to be a long-term maintenance dose. After completing the first four weeks on the 2.5mg dosage, your doctor will likely increase your dose to 5mg, which is when the medication begins to exert its primary blood sugar-lowering effects.

• Starting Dose for Treatment: The ideal starting point to introduce Mounjaro into your system.
• Reduces Side Effects: A low-dose design to minimize common side effects as you begin treatment.
• Prepares Your Body: Helps your body acclimate to the medication before moving to a therapeutic dose.
• Easy-to-Use KwikPen: Designed for simple and convenient once-weekly self-administration.

• Use Mounjaro exactly as prescribed by your doctor and follow all directions on your prescription label
• Preparation: Remove the pen from refrigerator. Leave the gray base cap on until you are ready to inject. Wipe your skin with a swab and let the injection site dry before you inject your dose. Pull off the gray base cap. Make sure the pen is locked. Do not unlock the Pen until you place the clear base on your skin and are ready to inject. Pull the gray base cap straight off and throw it away in your household trash. Insert the needle (needle sold separately, not included in this pack). Place the clear base flat against your skin at the injection. Do not mix insulin and Mounjaro together in the same injection.
•  Starting Treatment: The recommended starting dosage is 2.5mg once a week for the first four weeks. Do not increase your dose without a doctor's advice. You can inject the solution under the skin in your abdomen, the front of your thigh, or the back of your upper arm (with a caregiver). Rotate your injection site each week.
• Important Note: The 2.5mg dose is for treatment initiation and is not intended for long-term glycemic control.
• Important Warnings: Hypoglycemia - When used with other diabetes medicines, Mounjaro may cause low blood sugar.
• FDA Boxed Warning: Mounjaro carries a serious warning regarding the potential risk of thyroid C-cell tumors, including Medullary Thyroid Carcinoma (MTC). Do not use this medication if you or a family member have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Common Side Effects: The most common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, and stomach pain. These often lessen over time as your body adjusts.
• Serious Side Effects: Seek immediate medical attention if you experience symptoms of pancreatitis (severe stomach pain), severe allergic reaction, or gallbladder issues.
• Disclaimer: This product description is for informational purposes only and is not a substitute for professional medical advice. The details provided are based on the manufacturer's information. Always consult your doctor or a pharmacist for personalized advice, and read the full package insert before using the product.